NDC codes

FDA NDC Directory
Product NDC (as listed)71765-009Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71765-0009Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71765-009-01717650009012 BLISTER PACK in 1 BOX (71765-009-01) / 12 TABLET in 1 BLISTER PACKMarketed from Sep 26, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Amantadine Hydrochloride
Generic name (nonproprietary)
amantadine hydrochloride
Active ingredients
Amantadine hydrochloride — 100 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 218598
Marketing start
Listing expires
Other FDA classes
M2 Protein Inhibitors (Mechanism)
Identifiers
Product ID 71765-009_4df85675-4d84-2a33-e063-6394a90a9ddcSPL ID 4df85675-4d84-2a33-e063-6394a90a9ddcSPL set ID 9c5e0c61-372b-4d1b-8882-e13f6af8fed0RxCUI 849395UNII M6Q1EO9TD0
Pharmacologic class
Influenza A M2 Protein Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471765000901 followed by a unit qualifier and the quantity

Package 71765-0009-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Amantadine hydrochloride tablets are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride tablets are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. Influenza A Prophylaxis Amantadine hydrochloride tablets are indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection. Because amantadine hydrochloride tablets do not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protec…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in